The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-(6-(5-chloro-2-(tetrahydro-2H-pyran-4-ylamino)pyrimidin-4-yl)-1-oxoisoindolin-2-yl)-N-((S)-2-hydroxy-1-(6-(4-methylpiperazin-1-yl)pyridin-2-yl)ethyl)propanamide ID: ALA4856124
PubChem CID: 129053409
Max Phase: Preclinical
Molecular Formula: C32H39ClN8O4
Molecular Weight: 635.17
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C[C@H](C(=O)N[C@H](CO)c1cccc(N2CCN(C)CC2)n1)N1Cc2ccc(-c3nc(NC4CCOCC4)ncc3Cl)cc2C1=O
Standard InChI: InChI=1S/C32H39ClN8O4/c1-20(30(43)37-27(19-42)26-4-3-5-28(36-26)40-12-10-39(2)11-13-40)41-18-22-7-6-21(16-24(22)31(41)44)29-25(33)17-34-32(38-29)35-23-8-14-45-15-9-23/h3-7,16-17,20,23,27,42H,8-15,18-19H2,1-2H3,(H,37,43)(H,34,35,38)/t20-,27-/m1/s1
Standard InChI Key: FOWKCJGRLFZWNL-NFQMXDRXSA-N
Molfile:
RDKit 2D
45 50 0 0 0 0 0 0 0 0999 V2000
25.8117 -28.0855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5282 -27.6722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5253 -26.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8099 -26.4325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0970 -27.6726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0982 -26.8438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3102 -26.5863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8219 -27.2563 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.3082 -27.9275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2397 -28.0828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2397 -28.9089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9540 -29.3202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6687 -28.9065 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.6648 -28.0772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9499 -27.6697 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.3771 -27.6611 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0937 -28.0700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0931 -28.8963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8055 -29.3050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5204 -28.8924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.5181 -28.0665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8011 -27.6531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9969 -27.2551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5856 -26.5400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7606 -26.5388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9991 -25.8262 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.5255 -29.3218 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
24.0521 -28.7117 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.5834 -27.9689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3470 -27.2527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5220 -27.2515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7584 -27.9678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3449 -28.6816 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.1148 -26.5351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2905 -26.5335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8762 -27.2479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2920 -27.9654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1149 -27.9634 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8833 -28.6828 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0574 -28.6824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6465 -29.3937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0569 -30.1097 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8829 -30.1100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2983 -29.3943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6432 -30.8235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
2 10 1 0
14 16 1 0
16 17 1 0
17 18 1 0
17 22 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
8 23 1 0
23 24 1 0
24 25 1 0
24 26 2 0
11 27 1 0
9 28 2 0
23 29 1 6
25 30 1 0
30 31 1 0
30 32 1 6
32 33 1 0
31 34 2 0
34 35 1 0
35 36 2 0
36 37 1 0
37 38 2 0
38 31 1 0
39 40 1 0
39 44 1 0
40 41 1 0
41 42 1 0
42 43 1 0
43 44 1 0
37 39 1 0
42 45 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 635.17Molecular Weight (Monoisotopic): 634.2783AlogP: 2.73#Rotatable Bonds: 9Polar Surface Area: 136.05Molecular Species: NEUTRALHBA: 10HBD: 3#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.97CX Basic pKa: 7.53CX LogP: 1.97CX LogD: 1.60Aromatic Rings: 3Heavy Atoms: 45QED Weighted: 0.32Np Likeness Score: -1.06
References 1. Heightman TD, Berdini V, Bevan L, Buck IM, Carr MG, Courtin A, Coyle JE, Day JEH, East C, Fazal L, Griffiths-Jones CM, Howard S, Kucia-Tran J, Martins V, Muench S, Munck JM, Norton D, O'Reilly M, Palmer N, Pathuri P, Peakman TM, Reader M, Rees DC, Rich SJ, Shah A, Wallis NG, Walton H, Wilsher NE, Woolford AJ, Cooke M, Cousin D, Onions S, Shannon J, Watts J, Murray CW.. (2021) Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2., 64 (16.0): [PMID:34387469 ] [10.1021/acs.jmedchem.1c00905 ]